ZLAB News and Press, Zai Lab Limited From 11/08/23

2023-11-08 14:00:22 ET Zai Lab Limited (ZLAB) Q3 2023 Earnings Conference Call November 08, 2023 08:00 AM ET Company Participants Christine Chiou - Senior Vice President-Investor Relations Samantha Du - Founder, Chairperson & Chief Executive Officer Josh Smil...

2023-11-07 16:40:45 ET More on Zai Lab Zai Lab Stock: De-Risking Through Market Tapping Zai Lab Q3 2023 Earnings Preview Seagen, Genmab update Phase 3 data for uterine cancer therapy Seeking Alpha’s Quant Rating on Zai Lab Historical earnings d...

Total product revenue of $69.2 million for the third quarter of 2023, representing 22% y-o-y growth; 27% y-o-y growth at constant exchange rate (CER) VYVGART ® (efgartigimod alfa injection) achieved $4.9 million sales since its commercial launch in September in China ...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Zai Lab Limited (ZLAB) is expected to report $-0.94 for Q3 2023

2023-11-06 17:35:59 ET More on Zai Lab Zai Lab Stock: De-Risking Through Market Tapping Zai Lab Limited (ZLAB) Q2 2023 Earnings Call Transcript Seagen, Genmab update Phase 3 data for uterine cancer therapy Biggest stock movers today: Trip.com, Airbnb, Blackst...

2023-10-23 14:58:57 ET More on Genmab, Seagen, etc. Zai Lab Stock: De-Risking Through Market Tapping Seagen Acquisition By Pfizer: A Strategic Power Move With Potential Windfalls For Investors Genmab Is Down To Attractive Levels Seagen/ Astellas succeed in Ph...

SHANGHAI, China and CAMBRIDGE, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the third quarter of 2023 and recent corporate updates, after the closing of the U.S. equity markets on November 7, 2023. Th...

2023-09-26 14:17:50 ET More on Argenx, OmniAb, etc. OmniAb: Hold For Growth argenx: Three Important Milestones Reached In 2023, More To Come argenx: CIDP Data Better Than Expected, Maintaining Hold Rating argenx: Hytrulo Finally Approved, But CIDP Is A Bigger...

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for efgartigimod alfa injec...